Xiamen Amoytop Biotech Co., Ltd. (SHA:688278)
China · Delayed Price · Currency is CNY 76.54
-1.32 (-1.70%)
Nov 17, 2025, 2:15 PM CST
Xiamen Amoytop Biotech Market Cap
Xiamen Amoytop Biotech has a market cap or net worth of 31.67 billion as of November 14, 2025. Its market cap has decreased by -2.57% in one year.
Market Cap
31.67B
Enterprise Value
30.99B
Revenue
3.34B
Ranking
n/a
PE Ratio
33.70
Stock Price
76.54
Market Cap Chart
Since January 17, 2020, Xiamen Amoytop Biotech's market cap has increased from 14.36B to 31.67B, an increase of 120.57%. That is a compound annual growth rate of 14.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 31.67B | 6.12% |
| Dec 31, 2024 | 29.85B | 40.15% |
| Dec 29, 2023 | 21.30B | 34.47% |
| Dec 30, 2022 | 15.84B | 32.96% |
| Dec 31, 2021 | 11.91B | -14.13% |
| Dec 31, 2020 | 13.87B | -3.40% |
| Jan 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 417.34B |
| WuXi AppTec | 282.16B |
| Shenzhen Mindray Bio-Medical Electronics | 251.19B |
| Sichuan Biokin Pharmaceutical | 153.43B |
| Aier Eye Hospital Group | 113.87B |
| Shanghai United Imaging Healthcare | 112.24B |
| Zhangzhou Pientzehuang Pharmaceutical., | 109.07B |
| Yunnan Baiyao Group Co.,Ltd | 101.10B |